Ex- vivo cultured adult allogeneic MSCs
BiologicalSingle intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan
NCT Number: NCT01448434
This study is designed to know the safety and efficacy of 2 different doses of mesenchymal stem cells in patients suffering from osteoarthritis of knee joint.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Phase 2
Pantai Cheras Medical Centre, Kuala Lumpur, Malaysia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single intraarticular dose of allogeneic MSCs suspended in 2ml Plasmalyte followed by 2ml of Hyaluronan
Single intraarticular dose of 2ml Plasmalyte followed by 2ml Hyaluronan
Time frame: 1 year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Time frame: 1 Year
Stempeutics Research Pvt Ltd
Industry
A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06717529
Arthritis, Joint Diseases
Mostar, Bosnia and Herzegovina
View Trial DetailsNCT01055470
Osteoarthritis of Knee Joint
Bhavnagar, Gujarat, India
View Trial DetailsNCT07293949
Arthritis, Central Nervous System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial Details